SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

Mixed oncology-trial results are driving attention: traders cite BioNTechs BNT113 setback and modest breast-cancer benefit, while bulls point to other promising pipeline readouts and upcoming updates. Debate also reflects concern over the leadership transition and the time needed to turn the pipeline into commercial products.

Twilio, Inc. engages in the development of communications software, cloud-based platforms, and services. It operates through Twilio Communications and Twilio Segments. The Twilio Communications segment includes the platforms Messaging and Voice. The Twilio Segment involves Segment, Engage, Flex, Email, and others. The company was founded by John Wolthuis, Jeffery G. Lawson, and Evan Cooke in March 2008 and is headquartered in San Francisco, CA.

Twilio Inc - Ordinary Shares Class A

Twilio Inc

Twilios quarterly results beat expectations and lifted its full-year outlook, but a softer next-quarter organic growth forecast signaled deceleration and drove a sharp selloff. Traders are debating whether slowing messaging growth and weaker customer expansion outweigh the strong results, while some see the pullback as a potential bounce opportunity.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

SCHD is drawing attention as traders discuss a shift from volatile technology and growth stocks toward dividend-paying value and defensive holdings amid market uncertainty. Many point to its recent strength and keep accumulating, while others question its yield and warn that rising Treasury yields or a return to tech could weigh on the fund.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Traders are focused on whether Q3 results will show that oral Wegovy demand and international expansion can offset concerns about Eli Lillys competitive lead in GLP-1 drugs. The community is divided: some see the pill rollout and low valuation as recovery potential, while others remain cautious about Novos execution, management and pipeline; the Hengrui licensing deal also drew debate as a longer-term pipeline move.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A sharp breakout to a fresh 52-week high has put TGTX in focus, with traders pointing to BRIUMVIs commercial growth and anticipation of earnings and upcoming subcutaneous data. Buyout and short-squeeze theories are circulating, but remain speculation; others see the rally as momentum ahead of those catalysts.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvanas Q3 report, with record sales and revenue growth but an EPS miss and weaker margins, sparked a sharp rally and renewed short-squeeze speculation; traders are also citing the SECs decision to close its investigation without recommending enforcement. The move has drawn competing views, with bulls focused on growth and squeeze potential while bears question profitability, guidance and valuation.

Almonty Industries, Inc. engages in the mining, processing, and shipment of tungsten concentrates. Its projects include Almonty Korea Tungsten, Panasquiera mine, Gentung, Almonty Korea Moly, Los Santos mine, and Valtreixal. The company was founded on September 28, 2009 and is headquartered in Dillon, MT.

Almonty Industries Inc

A sharp selloff and persistent volatility dominate discussion, with traders pointing to broader weakness in miners and uncertainty over Sangdongs production ramp and near-term cash flows. Some remain bullish on tungsten-market fundamentals and the mines first shipment, while others say the investor-day discussion offered little new detail and are concerned about execution.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regenerons strong third-quarter earnings, supported by growth in Dupixent and Eylea HD, sparked a sharp share-price surge and a new 52-week high. Traders are broadly bullish on the breakout, while debating whether the move can hold or will retrace.

Crown Castle, Inc. engages in the business of owning, operating, and leasing shared communications infrastructure. It operates through the following segments: Towers, Fiber, and Other. The Towers segment focuses on providing coverage and capacity for wireless carrier network deployments. The Fiber segment includes communications infrastructure offerings of small cells and fiber solutions. The Other segment is involved in corporate assets such as cash and cash equivalents. The company was founded by Ted B. Miller Jr. and Edward C. Hutcheson Jr. in 1994 and is headquartered in Houston, TX.

Crown Castle Inc

Crown Castle International Corp

Reports that SpaceX is in talks to access at least 80,000 U.S. cell sites, including Crown Castles towers, have focused attention on the prospect of a major new leasing customer. Traders see potential tower revenue upside, while skeptics note that no agreement is signed and question whether SpaceXs wireless plans will translate into meaningful demand.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

A steep selloff in Aehr shares is driving discussion as traders debate whether broader AI and semiconductor weakness, valuation concerns and bearish options flow point to more downside or an oversold setup ahead of earnings. Bulls are watching guidance, backlog and potential AI test-system orders, while skeptics question execution and the companys ability to justify its valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NextNav Announces Date for Third Quarter 2026 Earnings Call

NextNav Inc. (NextNav) (NASDAQ: NN), a leader in next generation positioning, navigation, and timing (PNT) and 3D geolocation, today announced that it will release its results for the third quarter ended September 30, 2026 after market close on Tuesday, November 10, 2026, and will host a conference...

Spartacus Acquisition (NN) Surges 11.9%: Is This an Indication of Further Gains?

Spartacus Acquisition (NN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

NN Stock Soars As SpaceX Backs 900 MHz For Satellite Rules

Equity

SpaceX’s Oct. 23 filing urged the FCC to add the lower 900 MHz band to the list of spectrum eligible for expanded satellite-to-mobile service.


SpaceX’s 80,000 Cell Site Push A Win For AST SpaceMobile, Ericsson, Nokia, NextNav, Among Others, Says Roth Capital

SpaceX is reportedly pursuing agreements for a minimum of 80,000 cell sites across the United States as it advances plans to build a fourth nationwide wireless carrier.


Notable Wednesday Option Activity: NN, VRT, LQDA

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in NextNav Inc (Symbol: NN), where a total of 32,142 contracts have traded so far, representing approximately 3.2 million underlying shares. That amounts to about 102.9% of...

ATEX, NN, GOGO Stocks Gain: SpaceX’s $8B Spectrum Deal Could Boost Low-Band Spectrum Value, Says Roth Capital

Roth Capital said SpaceX’s spectrum acquisition could increase the value of low-band spectrum controlled by the three companies

10 Information Technology Stocks Moving In Friday's Pre-Market Session

Gainers

Veea (NASDAQ:VEEA) shares rose 43.7% to $5.56 during Friday's pre-market session. The market value of their outstanding shares is at $12.0 million.
NextNav (NASDAQ:NN) stock increased by 9.22% to $12.67.read more...

12 Information Technology Stocks Moving In Thursday's After-Market Session

Gainers

The Growhub (NASDAQ:TGHL) shares increased by 7.8% to $0.8 during Thursday's after-market session. The company's market cap stands at $19.7 million.
NextNav (NASDAQ:NN) shares rose 7.5% to $12.47. Theread more...

ASTS, SPCX And NN Stocks Slide: Clear Street Calls FCC Meeting Agenda Mixed For AST SpaceMobile 

Clear Street called the FCC’s October 29 agenda a mixed signal for AST SpaceMobile, favoring its carrier partnerships while flagging a real but narrow auction risk, and kept its ‘Buy’ rating.

NextNav and AiRANACULUS Partner to Advance Long-Range 5G Sensing and Counter-UAS Detection

NextNav Inc. (NASDAQ: NN), a leader in next-generation terrestrial Positioning, Navigation, and Timing (PNT) and 3D geolocation solutions, today announced a strategic partnership with AiRANACULUS, a developer of intelligent RF, signal processing, and advanced networking technologies, to advance...

NextNav, Inc. engages in development of positioning, navigation, and timing solutions. Its products include NextNav Pinnacle, NextNav 3D, and NextNav TerraPoiNT. The company was founded by Ganesh Pattabiraman and Arun Raghupathy in May 2021 and is headquartered in Reston, VA.

NextNav Inc

Bullish Sentiment

<ul class="summary-bullets"><li>NextNav holds the licenses and wants them reconfigured so it can build a ground-based GPS backup network.</li><li>Including the band would signal that low-band spectrum is useful for both satellite and terrestrial uses.</li><li>An earlier August SpaceX letter that referenced the same proposal previously lifted the stock.</li></ul>Shares of NextNav (NN) jumped 12% on Monday after SpaceX (SPCX) pushed for inclusion of its lower 900 MHz spectrum band in the Federal Communications Commission’s (FCC) proposed expansion of satellite-to-mobile spectrum.NextNav holds licenses in the lower 900 MHz band and has asked the FCC to reconfigure it so the company can build a ground-based network that delivers precise location and timing as a backup to GPS.SpaceX, in an Oct. 23 filing on the draft SCS 2.0 rules, recommended expanding the Supplemental Coverage from Space (SCS) framework and adding more spectrum bands, including 900 MHz. SCS allows satellite operators to fill coverage gaps by using terrestrial spectrum so ordinary phones can connect via satellite where there are no cell towers.“Doing so now saves time later: if the Commission grants the NextNav petition, authorizing direct-to-device service in the band requires no further rulemaking,” SpaceX said.The move raises the perceived value of NextNav’s licenses. It signals that a major satellite operator sees low-band spectrum as useful for both satellite and ground networks. NextNav wants the band for a reliable terrestrial complement to GPS that could support public safety and critical infrastructure. The proposed rules still require an FCC vote and further review.In August, SpaceX had <a href="https://stocktwits.com/news-articles/markets/equity/nn-stock-jumps-24-as-investors-cheer-space-x-s-nod-to-next-nav-spectrum-vision/cZoN3czRJX0">already pointed</a> to NextNav’s 900 MHz proposal as an area where fast-deployment requirements should apply, a filing that previously lifted the stock. That letter stressed that scarce radio airwaves should not sit idle.<h2 class="st-heading-2">How Did NN Retail Traders React?</h2>On Stocktwits, retail sentiment around <a class="mention" data-mention="$NN" data-symbol-id="NN" href="https://stocktwits.com/symbol/NN" target="_blank">NN stock</a> jumped from neutral to extremely bullish territory over the past 24 hours, while message volume increased from low to high levels.A Stocktwits user said that they are now feeling a “lil more optimistic” about the stock given that Elon Musk’s SpaceX wants the 900MHz spectrum.<stembedurl>https://stocktwits.com/Stupid83/message/667386719</stembedurl>Another user highlighted that NextNav might play a role in SpaceX’s ambitions to scale Starlink.&nbsp;<stembedurl>https://stocktwits.com/PassTheBread/message/667386221</stembedurl>NN stock has dropped 32% year-to-date.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/verizon-ceo-says-space-x-needs-4-6-years-and-hundreds-of-billions-to-rival-it-musk-says-it-will-take-less-time/cZU3BACRBz5">Verizon CEO Says SpaceX Needs 4–6 Years And Hundreds Of Billions To Rival It; Musk Says It Will Take Less Time</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the NextNav (Next Nav) logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

SpaceX’s Oct. 23 filing urged the FCC to add the lower 900 MHz band to the list of spectrum eligible for expanded satellite-to-mobile service.

SpaceX

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$11.52
Prev Close	$12.08
Open	$11.68
Dividend Yield	0.00%
50-Day Moving Average	$13.54
Beta	1.43
Avg. Volume	2.36M
PE Ratio	-11.74

52-Week High	$24.42
52-Week Low	$8.98
Market Capitalization	$1.94B
EPS (Annual)	-$1.42
Price to Book	5.75
Revenue Per Employee	$44,398.06

Feed

News

Sentiment

Earnings

Fundamentals

Info

NN Fundamentals